Edward-Phelps-Headshot

Phelps contributes to study on type 1 diabetes progression

November 3, 2025

A new study published in Cell Reports, co-led by University of Florida’s J. Crayton Pruitt Family Department of Biomedical Engineering associate professor Edward A. Phelps, Ph.D., and College of Veterinary Medicine chair and professor Clayton E. Mathews, Ph.D., reveals that beta cell dysfunction occurs independently of immune cell infiltration in the pancreas during the onset of […]

Read more »
Edward-Phelps-Headshot

Phelps appointed to NIH study section

September 16, 2025

Edward Phelps, Ph.D., associate professor in the J. Crayton Pruitt Family Department of Biomedical Engineering, has been invited to serve as a member of the Biomaterials and Biointerfaces Study Section, part of the Bioengineering Sciences and Technologies Integrated Review Group within the Center for Scientific Review at the National Institutes of Health. His term began […]

Read more »

Innovative Research Aims to Engineer Localized Immune Tolerance for Type 1 Diabetes Treatment

March 27, 2024

In an effort to address the unmet needs of immunoengineering for beta cell replacement in type 1 diabetes (T1D), Drs. Edward Phelps, Holger Russ, and Helen N. Jones are pioneering strategies aimed at locally controlling autoimmunity in T1D. Their research, poised to redefine treatment paradigms, focuses on leveraging immunomodulatory signals to promote tolerance towards grafted […]

Read more »

New Study Reveals Potential Breakthrough in Using Cell Messengers to Direct Immune Cell Behavior

June 8, 2023

Congratulations to Matthew Becker, Ph.D., on his first author paper titled, Immune Engineered Extracellular Vesicles to Modulate T Cell Activation in the Context of Type 1 Diabetes, being published in Science Advances. Dr. Matthew Becker, postdoctoral fellow, and Dr. Edward Phelps, assistant professor in the J. Crayton Pruitt Family Department of Biomedical Engineering, along with […]

Read more »